key: cord-0972718-5n8i15vm
authors: von Csefalvay, C.
title: VAERS data reveals no increased risk of neuroautoimmune adverse events from COVID-19 vaccines
date: 2021-06-15
journal: nan
DOI: 10.1101/2021.06.13.21258851
sha: f6ce61d4f06b4d2ec919e8bc6847d590446ce989
doc_id: 972718
cord_uid: 5n8i15vm

Neuroautoimmune disorders, such as multiple sclerosis and Guillain-Barre syndrome, have been documented in relation to various vaccines in the past. This paper uses passive reporting information from the CDC/FDA's VAERS system to analyse whether neuroautoimmune presentations are reported at a relatively higher or lower rate, vis-a-vis other adverse effects, for COVID-19 vaccines than for other vaccines. Through computing the reporting odds ratios for a range of symptoms and comparator vaccines, a clear indication in favour of the safety of COVID-19 vaccines emerges, with reports of neuroautoimmune adverse events in relation to other adverse events being over 70% less likely for COVID-19 than for comparator vaccines (ROR: 0.292, p < 0.0001). In comparison with other vaccines given as part of routine care in adulthood, COVID-19 vaccines have the lowest reporting odds ratio of neuroautoimmune adverse effects (median ROR: 0.246).

The global drive to curb the spread of COVID-19 through a concerted vaccination 15 effort is undoubtedly one of the most ambitious public health projects ever undertaken. Based on this encoding, the individual data was segmented and age distributions Data was cross-tabulated to yield a 2x2 contingency table for COVID-19 vs. non-117 COVID-19 vaccines (Table 1) , and the odds ratio was calculated using Fisher's exact test.

. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) This is confirmed by the Pearson χ 2 residuals that were calculated (see Table 2 ). The remains to be seen (especially given the low absolute numbers) whether this association 177 remains in evidence as more data accrues, or, as is more likely, it is part of the noisy 178 undercurrent that is characteristic of passive reporting.

. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The following abbreviations are used in this manuscript: 

Estimates of influenza vaccination coverage among adults-United States, 2017-18 flu 240 season

Vaccine hesitancy: the next challenge in the fight against COVID-19

Predictors of COVID-19 vaccine hesitancy in the UK household longitudinal 246 study

Vaccine hesitancy in the era of COVID-19

The Vaccine Adverse Event Reporting System (VAERS). Vaccine

Safety monitoring in the vaccine 270 adverse event reporting system (VAERS)

An overview of the vaccine adverse event reporting 273 system (VAERS) as a surveillance system

The reporting odds ratio and its advantages over the 275 proportional reporting ratio

others. pandas: a foundational Python library for data analysis and statistics

Python for High Performance and Scientific Computing

Econometric and statistical modeling with python

Proceedings of the 9th Python in Science Conference